These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37689493)

  • 1. "I Wasn't Presented With Options": Perspectives of Black Veterans Receiving Care for Uterine Fibroids in the Veterans Health Administration.
    Carey C; Silvestrini M; Callegari LS; Katon JG; Bossick AS; Doll KM; Christy A; Washington DL; Owens S
    Womens Health Issues; 2023; 33(6):652-660. PubMed ID: 37689493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Disparities in Uterine Fibroid Treatment Among Veterans Using VA Health Care.
    Katon JG; Bossick A; Carey C; Christy A; Doll K; Gatsby E; Gray KE; Lynch KE; Moy E; Owens S; Washington DL; Callegari LS
    Womens Health Issues; 2023; 33(4):405-413. PubMed ID: 37105835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine Weight as a Modifier of Black/White Racial Disparities in Minimally Invasive Hysterectomy Among Veterans with Fibroids in the Veterans Health Administration.
    Carey CM; Katon JG; Bossick AS; Gray KE; Doll KM; Christy AY; Callegari LS
    Health Equity; 2022; 6(1):909-916. PubMed ID: 36636115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative medical therapy before surgery for uterine fibroids.
    Lethaby A; Puscasiu L; Vollenhoven B
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids.
    Orellana M; Riggan KA; DSouza K; Stewart EA; Venable S; Balls-Berry JE; Allyse MA
    J Racial Ethn Health Disparities; 2022 Aug; 9(4):1184-1191. PubMed ID: 34013445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
    Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
    Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Black Women Are More Likely Than White Women to Schedule a Uterine-Sparing Treatment for Leiomyomas.
    Wegienka G; Stewart EA; Nicholson WK; Zhang S; Li F; Thomas L; Spies JB; Venable S; Laughlin-Tommaso S; Diamond MP; Anchan RM; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
    J Womens Health (Larchmt); 2021 Mar; 30(3):355-366. PubMed ID: 33524308
    [No Abstract]   [Full Text] [Related]  

  • 10. Black Women's Psychosocial Experiences with Seeking Surgical Treatment for Uterine Fibroids: Implications for Clinical Practice.
    VanNoy BN; Bowleg L; Marfori C; Moawad G; Zota AR
    Womens Health Issues; 2021; 31(3):263-270. PubMed ID: 33610438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between Race/Ethnicity, Uterine Fibroids, and Minimally Invasive Hysterectomy in the VA Healthcare System.
    Callegari LS; Katon JG; Gray KE; Doll K; Pauk S; Lynch KE; Uchendu US; Zephyrin L; Gardella C
    Womens Health Issues; 2019; 29(1):48-55. PubMed ID: 30293778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
    Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
    Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributors to Racial Disparities in Minimally Invasive Hysterectomy in the US Department of Veterans Affairs.
    Katon JG; Bossick AS; Doll KM; Fortney J; Gray KE; Hebert P; Lynch KE; Ma EW; Washington DL; Zephyrin L; Callegari LS
    Med Care; 2019 Dec; 57(12):930-936. PubMed ID: 31730567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine Fibroids in Black Women: A Race-Stratified Subgroup Analysis of Treatment Outcomes After Laparoscopic Radiofrequency Ablation.
    Berman JM; Bradley L; Hawkins SM; Levy B
    J Womens Health (Larchmt); 2022 Apr; 31(4):593-599. PubMed ID: 34287028
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.
    Hoffman SR; Vines AI; Halladay JR; Pfaff E; Schiff L; Westreich D; Sundaresan A; Johnson LS; Nicholson WK
    Am J Obstet Gynecol; 2018 Jun; 218(6):610.e1-610.e7. PubMed ID: 29432754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "In our community, we normalize pain": discussions around menstruation and uterine fibroids with Black women and Latinas.
    Orellana M; DSouza KN; Yap JQ; Sriganeshan A; Jones ME; Johnson C; Allyse M; Venable S; Stewart EA; Enders F; Balls-Berry JE
    BMC Womens Health; 2024 Apr; 24(1):233. PubMed ID: 38610011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Informational Preferences of Women Seeking Treatment for Symptomatic Uterine Fibroids: A Qualitative Study.
    Wolgemuth T; Suresh N; Holder K; Milad MP
    J Minim Invasive Gynecol; 2023 Apr; 30(4):284-289. PubMed ID: 36528257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.